The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Giliarevskiĭ S.R.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo;
kafedra klinicheskoĭ farmakologii i terapii RMAPO

Golshmid M.V.

Federal state-funded educational institution DPO RMANPO of Ministry of Health of the Russia, Moscow, Russia

Zakharova G.Yu.

Federal state-funded educational institution DPO RMANPO of Ministry of Health of the Russia, Moscow, Russia

Kuz'mina I.M.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo;
kafedra klinicheskoĭ farmakologii i terapii RMAPO

Sinitsina I.I.

Federal state-funded educational institution DPO RMANPO of Ministry of Health of the Russia, Moscow, Russia

Hypomagnesemia and magnesium deficiency as risk factors for the development of complications of cardiovascular diseases

Authors:

Giliarevskiĭ S.R., Golshmid M.V., Zakharova G.Yu., Kuz'mina I.M., Sinitsina I.I.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2019;12(5): 459‑466

DOI: 10.17116/kardio201912051459

Views: 15260

Downloaded: 343

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Giliarevskiĭ SR, Golshmid MV, Zakharova GYu, Kuz'mina IM, Sinitsina II. Hypomagnesemia and magnesium deficiency as risk factors for the development of complications of cardiovascular diseases. Russian Journal of Cardiology and Cardiovascular Surgery. 2019;12(5):459‑466. (In Russ.)
https://doi.org/10.17116/kardio201912051459

 
МСФ на ЯМ
Close metadata
Recommended articles:
Gender differences in mental and beha­vioural diso­rders as an impo­rtant stage of cardiovascular diseases prevention in young people. Russian Journal of Preventive Medi­cine. 2024;(3):66-71
Possibilities of cardiometabolic diseases prevention in women with pregnancy adve­rse outcomes in medi­cal history. Russian Journal of Preventive Medi­cine. 2024;(3):98-103
Influence of inte­stinal microbiota on cardiovascular athe­rosclerotic diseases and colo­rectal cancer in elde­rly patients. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(1):30-36
Patients with ischaemic heart disease and non-steroidal anti-inflammatory drugs dosing — reco­mmendations and real-life clinical setting. Russian Journal of Preventive Medi­cine. 2024;(6):68-73
Pathophysiological mechanisms of vascular wall alte­rations in meno­pausal women. Russian Journal of Preventive Medi­cine. 2024;(6):91-97
Mammographic markers of the cardiovascular risk. Russian Journal of Preventive Medi­cine. 2024;(7):77-84
Biochemical markers of inflammation and their asso­ciation with hostility, social gradient and beha­vior in persons aged 25—44 years. Russian Journal of Preventive Medi­cine. 2024;(8):45-52
Clinical consequences of sarcopenic obesity. Part 1. Non-alcoholic fatty liver disease, type 2 diabetes mellitus, chro­nic kidney disease. Russian Journal of Preventive Medi­cine. 2024;(8):114-120
Clinical consequences of the sarcopenic obesity. Part 2. Cardiovascular diseases and osteoporosis. Russian Journal of Preventive Medi­cine. 2024;(9):60-66
Possibilities of coro­nary artery calcification asse­ssment for cardiovascular risk stra­tification. Russian Journal of Preventive Medi­cine. 2024;(9):117-122

This paper reviews the complex interaction between chronic deficit of magnesium and risk of different diseases and its complications. Causes of magnesium deficit and its consequences are discussed. Contemporary methods of diagnoses of magnesium with specific invasive tests are also reviewed. The role of magnesium deficit in the development of coronary heart disease and dangerous heart arrhythmias is mentioned in the article. New data about the relations between polypharmacotherapy in the elderly and risk of magnesium deficit. Role of alcoholism in the development of such complication is also discussed. Influence of magnesium supplementation on blood pressure is also mentioned. As for the treatment of magnesium deficit the review emphasizes the role of orotate magnesium.

Keywords:

deficit of magnesium
cardiovascular diseases
hypomagnesemia

Authors:

Giliarevskiĭ S.R.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo;
kafedra klinicheskoĭ farmakologii i terapii RMAPO

Golshmid M.V.

Federal state-funded educational institution DPO RMANPO of Ministry of Health of the Russia, Moscow, Russia

Zakharova G.Yu.

Federal state-funded educational institution DPO RMANPO of Ministry of Health of the Russia, Moscow, Russia

Kuz'mina I.M.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo;
kafedra klinicheskoĭ farmakologii i terapii RMAPO

Sinitsina I.I.

Federal state-funded educational institution DPO RMANPO of Ministry of Health of the Russia, Moscow, Russia

List of references:

  1. Ismail AAA, Ismail Y, Ismail AA. Chronic magnesium deficiency and human disease; time for reappraisal? QJM. 2018 Nov 1;111(11):759-763. https://doi.org/10.1093/qjmed/hcx186
  2. Whang R. Routine serum magnesium determination-a continuing unrecognized need. Magnesium. 1987;6:1-4.
  3. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95:1-46. https://doi.org/10.1152/physrev.00012.2014
  4. Costello RB, Elin RJ, Rosanoff A, et al. Perspective: the case for an evidence-based reference interval for serum magnesium: The time has come. Adv Nutr. 2016;7:977-993.
  5. Van Laecke S. Hypomagnesemia and hypermagnesemia. Acta Clin Belg. 2019;74:41-47. https://doi.org/10.1080/17843286.2018.1516173
  6. Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, et al. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am J Kidney Dis. 2015;66:775-782. https://doi.org/10.1053/j.ajkd.2015.05.012
  7. Schimatschek HF, Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res. 2001;14:283-290.
  8. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk Communities Study. J Clin Epidemiol. 1995;48:927-940. https://doi.org/10.1016/0895-4356(94)00200-A
  9. Viering DHHM, de Baaij JHF, Walsh SB, et al. Genetic causes of hypomagnesemia, a clinical overview. Pediatr Nephrol. 2017;32:1123-1135. https://doi.org/10.1007/s00467-016-3416-3
  10. Barbagallo M, Di Bella G, Brucato V, et al. Serum ionized magnesium in diabetic older persons. Metabolism. 2014;63:502-509. https://doi.org/10.1016/j.metabol.2013.12.003
  11. Kieboom BCT, Ligthart S, Dehghan A, et al. Serum magnesium and the risk of prediabetes: a population-based cohort study. Diabetologia. 2017;60:843-853. https://doi.org/10.1007/s00125-017-4224-4
  12. Lecube A, Baena-Fustegueras JA, Fort JM, et al. Diabetes is the main factor accounting for hypomagnesemia in obese subjects. PLoS One. 2012;7(1):e30599. https://doi.org/10.1371/journal.pone.0030599
  13. Muñoz-Castañeda JR, Pendón-Ruiz de Mier MV, Rodríguez M, et al. Magnesium replacement to protect cardiovascular and kidney damage? Lack of prospective clinical trials. Int J Mol Sci. 2018;19:3. https://doi.org/10.3390/ijms19030664
  14. Nielsen FH, Lukaski HC. Update on the relationship between magnesium and exercise. Magnes Res. 2006;19:180-189. https://doi.org/10.1684/mrh.2006.0060
  15. Shahi A, Aslani S, Ataollahi M, Mahmoudi M. The role of magnesium in different inflammatory diseases. Inflammopharmacology. 2019;27:649-661. https://doi.org/10.1007/s10787-019-00603-7
  16. Hansen BA, Bruserud Ø. Hypomagnesemia in critically ill patients. J Intensive Care. 2018;6:21. eCollection 2018. https://doi.org/10.1186/s40560-018-0291-y
  17. Skou JC, Butler KW, Hansen O. The effect of magnesium, ATP, P I, and sodium on the inhibition of the (Na++ K + )-activated enzyme system by g-strophanthin. Biochim Biophys Acta. 1971;241:443-461. https://doi.org/10.1016/0005-2736(71)90044-7
  18. Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999;10:1616-1622.
  19. DiNicolantonio JJ, O’Keefe JH, Wilson W. Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart. 2018;5(1):e000668. eCollection 2018. https://doi.org/10.1136/openhrt-2017-000668
  20. Whang R, Hampton EM, Whang DD. Magnesium homeostasis and clinical disorders of magnesium deficiency. Ann Pharmacother. 1994;28:220-226. https://doi.org/10.1177/106002809402800213
  21. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1998;136:480-490. https://doi.org/10.1016/s0002-8703(98)70224-8
  22. Schulze MB, Schulz M, Heidemann C, et al. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med. 2007;167:956-965. https://doi.org/10.1001/archinte.167.9.956
  23. Shechter M. Magnesium and cardiovascular system. Magnes Res. 2010;23:60-72. https://doi.org/10.1684/mrh.2010.0202
  24. Misialek JR, Lopez FL, Lutsey PL, et al. Serum and Dietary Magnesium and Incidence of Atrial Fibrillation in Whites and in African Americans. Circ J. 2013;77:323-329.
  25. Khan AM, Lubitz SA, Sullivan LM, et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham heart study. Circulation. 2013;127:33-38. https://doi.org/10.1161/CIRCULATIONAHA.111.082511
  26. Dyckner T. Serum magnesium in acute myocardial infarction. Relation to arrhythmias. Acta Med Scand. 1980;207:59-66.
  27. Rasmussen HS, Suenson M, McNair P, et al. Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double-blind placebo-controlled study. Clin Cardiol. 1987;10:351-356. https://doi.org/10.1002/clc.4960100610
  28. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339:1553-1558. https://doi.org/10.1016/0140-6736(92)91828-v
  29. ISIS-4 Collaborative Group. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) collaborative group. Lancet. 1995;345:669-685. https://doi.org/10.5555/uri:pii:S014067369590865X
  30. The Magnesium in Coronaries (MAGIC) Trial Investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the magnesium in coronaries (MAGIC) trial: a randomized controlled trial. Lancet. 2002;360:1189-1196. https://doi.org/10.1016/s0140-6736(02)11278-5
  31. Klevay LM, Milne DB. Low dietary magnesium increases supraventricular ectopy. Am J Clin Nutr. 2002;75:550-554.
  32. Nielsen FH, Milne DB, Klevay LM, et al. Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in postmenopausal women. J Am Coll Nutr. 2007;26:121-132.
  33. Sasaki S, Oshima T, Matsuura H, et al. Abnormal magnesium status in patients with cardiovascular diseases. Clin Sci. 2000;98:175-181.
  34. Chipperfield B, Chipperfield JR. Magnesium and the heart. Am Heart J. 1977;93:679-682.
  35. Papaceit J, Moral V, Recio J, et al. Severe heart arrhythmia secondary to magnesium depletion. Torsade de pointes. Rev Esp Anestesiol Reanim. 1990;37:28-31.
  36. Iseri LT. Role of magnesium in cardiac tachyarrhythmias. Am J Cardiol. 1990;65:K47-K50.
  37. Torshin IYu, Gromova OA, Kalacheva AG, et al. Metaanaliz klinicheskikh issledovaniy vozdeystviya orotata magniya na serdechno-sosudistuyu sistemy. Ter arkhiv. 2015;87:88-97. (In Russ.) https://doi.org/10.17116/terarkh201587688-97
  38. Kubena KS, Durlach J. Historical review of the effects of marginal intake of magnesium in chronic experimental magnesium deficiency. Magnes Res. 1990;3:219-226.
  39. Severino P, Netti L, Mariani MV, et al. Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency. Cardiol Res Pract. 2019;2019:4874921. eCollection 2019. https://doi.org/10.1155/2019/4874921
  40. Elisaf M, Merkourpoulos M, Tsianos EV, et al. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995;9:210-214.
  41. Agus AS. Hypomagnesemia. J Am Soc Nephrol. 1999;10:1616-1622.
  42. Passman R, Kadish A. Polymorphic ventricular tachycardia, long Q—T syndrome, and torsades de pointes. Med Clin North Am. 2001;85:321-341.
  43. Khan IA. Long QT syndrome: diagnosis and management. Am Heart J. 2002;143:7-14.
  44. Sharain K, May AM, Gersh BJ. Chronic Alcoholism and the Danger of Profound Hypomagnesemia. Am J Med. 2015;128:e17-e18. https://doi.org/10.1016/j.amjmed.2015.06.051
  45. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary pat-terns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-1124.
  46. Zhang X, Li Y, Del Gobbo LC, et al. Effects of Magnesium Supplementation on Blood Pressure: A Metaanalysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension. 2016;68:324-333. https://doi.org/10.1161/HYPERTENSIONAHA.116.07664
  47. Peng JP, Zheng H. Kidney stones may increase the risk of coronary heart disease and stroke: A PRISMA-Compliant meta-analysis. Medicine (Baltimore). 2017;96(34):e7898. https://doi.org/10.1097/MD.0000000000007898
  48. Wu J, Yang Z, Wei J, et al. Association between Serum Magnesium and the Prevalence of Kidney Stones: a Cross-sectional Study. Biol Trace Elem Res. 2019 Jul 23. [Epub ahead of print]. https://doi.org/10.1007/s12011-019-01830-3
  49. Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006;367(9507):333-344. https://doi.org/10.1016/s0140-6736(06)68071-9
  50. Li MK, Blacklock NJ, Garside J. Effects of magnesium on calcium oxalate crystallization. J Urol. 1985;133:123-125.
  51. Resnick MI, Munday D, Boyce WH. Magnesium excretion and calcium oxalate urolithiasis. Urology. 1982;20:385-389.
  52. Kohri K, Garside J, Blacklock NJ. The role of magnesium in calcium oxalate urolithiasis. Br J Urol. 1988;61:107-115.
  53. Tiselius HG. Epidemiology and medical management of stone disease. BJU Int. 2003;91:758-767. https://doi.org/10.1046/j.1464-410X.2003.04208.x
  54. Liebman M, Costa G. Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol. 2000;163:1565-1569.
  55. Oktora MP, Denig P, Bos JHJ, et al. Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States. PLoS One. 2019;14:e0214240. eCollection 2019. https://doi.org/10.1371/journal.pone.0214240
  56. van Orten-Luiten ACB, Janse A, Verspoor E, et al. Drug use is associated with lower plasma magnesium levels in geriatric outpatients; possible clinical relevance. Clin Nutr. 2018 Dec 6. https://doi.org/10.1016/j.clnu.2018.11.018
  57. Schuchardt JP, Hahn A. Intestinal absorption and factors influencing bioavailability of magnesium-an update. Curr Nutr Food Sci. 2017;13:260-278.
  58. Coudray C, Rambeau M, Feillet-Coudray C, et al. Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnes Res. 2005;18:215-223.
  59. Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003;16:183-191.
  60. Kappeler D, Heimbeck I, Herpich C, et al. Higher bioavailability of magnesium citrate as compared to magnesium oxide shown by evaluation of urinary excretion and serum levels after single-dose administration in a randomized cross-over study. BMC Nutr. 2017;3:7. https://doi.org/10.1186/s40795-016-0121-3
  61. Gromova OA, Torshin IYu, Kalacheva AG. Metabolomny kompendium no magniyu orotatu. Effectivnaya farmakoterapiya. 2015;44:14-26. (In Russ.)
  62. Salerno C, Crifo C. Diagnostic value of urinary orotic acid levels: applicable separation methods. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;781(1-2):57-71.
  63. Motyl T, Krzeminski J, Podgurniak M, et al. Variability of orotic acid concentration in cow’s milk. Endocr Regul. 1991;25(1-2):79-82.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.